Ortin Laboratories Share PriceOrtin Laboratories

₹19.1
-0.2 (-1.04%)
As on 27 September, 2023 | 10:35 BSE: 539287 NSE: ORTINLABISIN: INE749B01020

Ortin Laboratories Performance

Day Range

  • Low 19.1
  • High 20
19.1

52 Week Range

  • Low 16.2
  • High 30.35
19.1
  • Open Price20
  • Previous Close19.3
  • Volume564

Start SIP in Ortin Laboratories

Start SIP

Ortin Laboratories Share Price

  • Over 1 Month -3.05%
  • Over 3 Month -17.32%
  • Over 6 Month -4.02%
  • Over 1 Year -17.67%

Ortin Laboratories Key Statistics

P/E Ratio 41.3
PEG Ratio 0.3
Market Cap Cr 16
Price to Book Ratio 1.4
EPS -0.1
Dividend 0
Relative Strength Index 40.71
Money Flow Index 28.73
MACD Signal -0.09
Average True Range 0.74

Ortin Laboratories Investment Rating

  • Master Rating:
  • Ortin Laboratories has an operating revenue of Rs. 4.97 Cr. on a trailing 12-month basis. An annual revenue de-growth of -28% needs improvement, Pre-tax margin of -1% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 27%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 57 which is a POOR score indicating inconsistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Ortin Laboratories Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 211132
Operating Expenses Qtr Cr 121123
Operating Profit Qtr Cr 001000
Depreciation Qtr Cr 000000
Interest Qtr Cr 000000
Tax Qtr Cr 000000
Net Profit Qtr Cr 000000
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 68
Operating Expenses Annual Cr 58
Operating Profit Annual in Cr 10
Depreciation Cr 00
Interest Annual Cr 01
Tax Annual Cr 00
Net Profit Annual Cr 00
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 2
Cash from Investing Activity Annual Cr 0
Cash from Financing Annual Activity Cr 0
Net Cash Flow Annual Cr 2
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 1111
Fixed Assets Annual Cr 1415
Total Non Current Assets Annual Cr 1515
Total Current Assets Annual Cr 76
Total Assets Annual Cr 2121
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 1313
ROE Annual % -1-4
ROCE Annual % 22
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 97
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Ortin Laboratories Technicals

EMA & SMA

Current Price
₹19.1
-0.2 (-1.04%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹19.69
  • 50 Day
  • ₹19.99
  • 100 Day
  • ₹20.41
  • 200 Day
  • ₹21.23
  • 20 Day
  • ₹19.73
  • 50 Day
  • ₹19.85
  • 100 Day
  • ₹20.54
  • 200 Day
  • ₹21.32

Ortin Laboratories Resistance and Support

PIVOT
₹19.37
Resistance
First Resistance ₹19.59
Second Resistance ₹19.87
Third Resistance ₹20.09
RSI 40.71
MFI 28.73
MACD Single Line -0.09
MACD -0.1
Support
First Resistance ₹19.09
Second Resistance ₹18.87
Third Resistance ₹18.59

Ortin Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 6,391 639,100 100
Week 9,970 997,000 100
1 Month 11,625 1,162,510 100
6 Month 63,774 3,965,472 62.18

Ortin Laboratories Result Highlights

Ortin Laboratories Synopsis

NSE-Medical-Diversified

Ortin Laborator. belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 6.02 Cr. and Equity Capital is Rs. 8.13 Cr. for the Year ended 31/03/2023. Ortin Laboratories Ltd. is a Public Limited Listed company incorporated on 27/10/1986 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1986PLC006885 and registration number is 006885.
Market Cap 16
Sales 5
Shares in Float 0.76
No of funds
Yield
Book Value 1.44
U/D Vol ratio 0.6
LTDebt / Equity 27
Alpha -0.05
Beta 0.22

Ortin Laboratories

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 7.36%21.51%15.68%15.68%
Foreign Portfolio Investors
Individual Investors 86.93%73.83%79.59%77.73%
Others 5.71%4.66%4.73%6.59%

Ortin Laboratories Management

Name Designation
Mr. J R K Panduranga Rao Chairman & Managing Director
Mr. S Murali Krishna Murthy Managing Director
Mr. S Srinivas Kumar WholeTime Director & CFO
Mr. G Venkata Ramana Non Executive Director
Mr. Bh Satyanarayana Raju Non Executive Director
Mr. S Balaji Venkateswarlu Non Executive Director
Mr. B Gopal Reddy Independent Director
Mr. Murali Krishna Rayaprolu Independent Director
Ms. Pottur Sujatha Independent Director

Ortin Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ortin Laboratories Corporate Action

Date Purpose Remarks
2023-08-14 Quarterly Results
2023-05-30 Audited Results
2023-02-14 Quarterly Results
2022-11-14 Quarterly Results
2022-08-13 Quarterly Results
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Ortin Laboratories FAQs

What is Share Price of Ortin Laboratories ?

Ortin Laboratories share price is ₹19 As on 27 September, 2023 | 10:21

What is the Market Cap of Ortin Laboratories ?

The Market Cap of Ortin Laboratories is ₹15.5 Cr As on 27 September, 2023 | 10:21

What is the P/E ratio of Ortin Laboratories ?

The P/E ratio of Ortin Laboratories is 41.3 As on 27 September, 2023 | 10:21

What is the PB ratio of Ortin Laboratories ?

The PB ratio of Ortin Laboratories is 1.4 As on 27 September, 2023 | 10:21

Q2FY23